TRENZLO Trademark

Trademark Overview

On Monday, February 24, 2014, a trademark application was filed for TRENZLO with the United States Patent and Trademark Office. The USPTO has given the TRENZLO trademark a serial number of 86202636. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 30, 2017. This trademark is owned by Novartis AG. The TRENZLO trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical and biological preparations for medical diagnostic use; pharmaceutical and biological preparations for medical use, namely, for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system and the genitourinary system, for the treatment of inflammatory disorders; pharmaceutical and biological preparations for medical use, namely, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; anti-fungal, anti-infective, antiviral and antibiotic preparations
trenzlo

General Information

Serial Number86202636
Word MarkTRENZLO
Filing DateMonday, February 24, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 30, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 29, 2014

Trademark Statements

Goods and Servicespharmaceutical and biological preparations for medical diagnostic use; pharmaceutical and biological preparations for medical use, namely, for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system and the genitourinary system, for the treatment of inflammatory disorders; pharmaceutical and biological preparations for medical use, namely, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; anti-fungal, anti-infective, antiviral and antibiotic preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, March 8, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, October 30, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 30, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 28, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 27, 2017EXTENSION 5 GRANTED
Tuesday, March 21, 2017EXTENSION 5 FILED
Tuesday, March 21, 2017TEAS EXTENSION RECEIVED
Friday, October 7, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 6, 2016EXTENSION 4 GRANTED
Sunday, September 18, 2016EXTENSION 4 FILED
Sunday, September 18, 2016TEAS EXTENSION RECEIVED
Thursday, March 24, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 23, 2016EXTENSION 3 GRANTED
Friday, March 18, 2016EXTENSION 3 FILED
Friday, March 18, 2016TEAS EXTENSION RECEIVED
Tuesday, September 29, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 28, 2015EXTENSION 2 GRANTED
Thursday, September 17, 2015EXTENSION 2 FILED
Friday, September 25, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 17, 2015TEAS EXTENSION RECEIVED
Thursday, March 19, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 17, 2015EXTENSION 1 GRANTED
Tuesday, March 17, 2015EXTENSION 1 FILED
Tuesday, March 17, 2015TEAS EXTENSION RECEIVED
Tuesday, September 23, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 29, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 29, 2014PUBLISHED FOR OPPOSITION
Wednesday, July 9, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 8, 2014ASSIGNED TO EXAMINER
Thursday, June 26, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 24, 2014ASSIGNED TO LIE
Friday, June 6, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 5, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 5, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 5, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 2, 2014NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, June 2, 2014PRIORITY ACTION E-MAILED
Monday, June 2, 2014PRIORITY ACTION WRITTEN
Saturday, May 31, 2014ASSIGNED TO EXAMINER
Saturday, March 8, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 27, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

trenzlo disorders system diseases preparations pharmaceutical treatment biological medical namely prevention